Mycobacteria other than *Mycobacterium tuberculosis* (MOTT), also collectively called non-tuberculous mycobacteria (NTM), were described more than 50 years ago. They have been isolated from pulmonary, lymph node, skin, soft tissue, skeletal, and disseminated infections as well as during nosocomial outbreaks related to inadequate disinfection/sterilization of medical devices ([@b9],[@b13]). NTM are acid-fast bacilli (AFB), morphologically similar to tuberculosis bacilli, and are ubiquitously distributed in the environment. Isolation of such bacteria from clinical specimens can represent either colonization or disease.

Isolates from sterile sites should be always considered as indicative of disease, but the clinical significance of isolates from non-sterile sites depends on the association of relevant clinical and epidemiological data ([@b3]). The American Thoracic Society recommends that NTM should be cultured from two separate expectorated sputum samples or at least from one bronchial wash or lavage to corroborate the diagnosis of NTM pulmonary disease in patients with pulmonary symptoms or suggestive images on chest radiograph ([@b10]). In Brazil, a publication from Centro de Vigilância Epidemiológica "Alexandre Vranjac" and Institute Adolfo Lutz from São Paulo classified the clinical significance of isolates in suggestive, potentially suggestive, and rarely suggestive of disease, according to microbiological criteria, as follows ([@b4]):

  Disease                  Mycobacterial species    Type of specimen   Number of specimens
  ------------------------ ------------------------ ------------------ ---------------------
  Suggestive               Potentially pathogenic   Sterile site       one
                                                    Non-sterile site   At least three
  Potentially suggestive   Potentially pathogenic   Non-sterile site   two
  Rarely suggestive        Rare pathogen            Non-sterile site   One or two

NTM have become relevant after the beginning of the Aids pandemic ([@b9]). The morbidity and mortality impact of NTM in HIV-positive patients stimulated studies on epidemiology, ecology, genetics and molecular biology of mycobacteria. The recent increase in occurrence of mycobacterioses also led to the development of rapid identification methods, reducing time for diagnosis and for institution of specific treatment, increasing chances of therapeutic success ([@b7]).

Studies on the morbidity and mortality impact of mycobacterioses in Brazil are scarce and there is no report on the occurrence these infections in the State of Mato Grosso do Sul ([@b2]). The Central Public Health Laboratory from Mato Grosso do Sul is the reference laboratory for tuberculosis diagnosis and receives specimens from 77 cities of Mato Grosso do Sul State for bacilloscopy and culture. Identification of mycobacteria is not routinely performed.

Here we report a descriptive retrospective study of all AFB positive samples received by this laboratory in the period of January 2003 to May 2004 and the analysis of clinical and epidemiological data from patients with NTM positive cultures. This project was approved by the Ethics Committee from the Federal University of Mato Grosso do Sul number 364.

From 2,923 clinical samples received in the study period, 267 presented AFB smear positive results. These specimens were decontaminated by the Petroff method and cultivated on solid Löwenstein-Jensen (L-J) or Ogawa-Kudoh media, and in liquid Middlebrook 7H9 medium using the MGIT system (Mycobacteria Growth Indicator Tube, Beckton Dickinson, USA). Presence of AFB in positive cultures was confirmed by bacilloscopy after Ziehl-Neelsen staining. One hundred and fifty-one positive cultures were presumptively identified as *M. tuberculosis* by analysis of colony morphology (rough) and pigmentation (nonchromogen), and the presence of cord on bacilloscopy ([@b14]). Forty additional cultures did not present these characteristics at the first examination and were regarded as NTM. They were identified by traditional methods, which included analysis of phenotypic properties (growth rate, pigment production, growth in different temperatures) and results of biochemical tests (nitrate reduction, catalase activity, urease activity, tween 80 hydrolysis, arylsulfatase) at the Central Laboratory of Instituto Adolfo Lutz from São Paulo ([@b6]).

Molecular identification was performed concomitantly, by a different team, using the method of PCR-Restriction Enzyme Analysis (PRA) with the *hsp65* gene as target. DNA from all isolates was obtained from a loop full of bacteria from solid plates, resuspended in ultra pure water and subjected to three freezing and boiling cycles of ten minutes each. A 441 bp fragment of the *hsp65* gene was amplified by PCR with primers Tb11 (5'- ACCAACGATGGTGTGTCCAT) and Tb12 (5'-CTTGTCG AACCGCATACCCT) and subjected to enzymatic restriction with *BstE* II and *Hae* III, as described by Telenti *et al*. ([@b17]). Enzymatic digestion products were visualized after electrophoresis in 4% agarose gels (FMC, Biologia Molecular do Brasil) stained with ethidium bromide. Images were captured in Polaroid films and restriction patterns were analyzed using the GelCompar II program v. 2.5 (AppliedMaths, Sint-Marten Latten, Belgium). Calculated restriction fragment sizes were compared to published patterns ([@b13],[@b15]) and to the patterns reported on the PRAsite (<http://app.chuv.ch/prasite>).

Eight of these 40 isolates were identified as *M. tuberculosis* by both identification methods and were excluded from this study. Considering the remaining 32 positive cultures, obtained from 28 patients, traditional identification assigned 17 (53.1%) isolates a mycobacterial species or complex, one culture was presumptively identified as *Nocardia*, 12 cultures presented ambiguous phenotypic results and were classified in groups according to growth rate and pigmentation, and two cultures were contaminated (Table 1).

###### 

Identification results of AFB isolates analyzed in this work and patients' demographic data.

  No       PATIENT   ORIGIN         PRA-*hsp65*                           TI                SPECIMEN           HIV
  -------- --------- -------------- ------------------------------------- ----------------- ------------------ -----
  **1**    A         Campo Grande   *M. avium* 1                          MAC               bone marrow        P
  **2**    B         Corumbá        *M. avium* 1                          MAC               Sputum             N
  **3**    C         Campo Grande   *M. avium* 1                          MAC               bone marrow        P
  **4**    D         Campo Grande   *M. avium* 2                          MAC               Sputum             N
  **5**    E         Campo Grande   *M. avium* 2                          MAC               Sputum             N
  **6**    F         (indigenous)   *M. avium* 2                          MAC               Sputum             N
  **7**    G         Campo Grande   *M. avium* 2                          MAC               Faeces             P
  **8**    H         Corumbá        *M. fortuitum* 1                      *M. fortuitum*    bronchial lavage   N
  **9**    I         (indigenous)   *M. fortuitum* 1                      *M. fortuitum*    Sputum             N
  **10**   J         Corumbá        *M. fortuitum* 1                      *M. fortuitum*    Sputum             NA
  **11**   K         Angélica       *M. kansasii* 5                       *M. kansasii*     Sputum             N
  **12**   L         Itaporã        *M. flavescens* 1                     *M. flavescens*   Sputum             N
  **13**   M         Rio Negro      *M. peregrinum* 2                     *M. peregrinum*   Sputum             N
  **14**   N         Campo Grande   *N. brasiliensis*                     *Nocardia*        Sputum             N
  **15**   O         Aquidauana     [^\*^](#tf2-1){ref-type="table-fn"}   MAC               Blood              P
  16                                *M. peregrinum* 2                     MAC               bone marrow        P
  17       P         Miranda        *M. peregrinum* 2                     contaminated      Sputum             N
  18       Q         (indigenous)   *M. lentiflavum* 3                    SGE               Sputum             N
  19       R         (indigenous)   *M. lentiflavum* 2                    RGE               Sputum             N
  20       S         Pedro Gomes    *M. vaccae* 1                         RGE               bone marrow        N
  21       T         Campo Grande   mixed                                 MAC               Sputum             N
  22       U         Corumbá        NP1                                   SGA               Sputum             P
  23                                NP1                                   SGA               Sputum             P
  24       V         Corumbá        NP2                                   RGA               Sputum             N
  25                                NP2                                   RGE               Sputum             N
  26       W         Rio Negro      NP3                                   SGE               Sputum             N
  27                                NP4                                   RGE               Sputum             N
  28       X         Aquidauana     NP5                                   *M. gordonae*     Sputum             N
  29       Y         (indigenous)   NP6                                   contaminated      Sputum             N
  30       Z         Campo Grande   NP7                                   SGE               Sputum             NA
  31       AA        Campo Grande   NP8                                   RGE               Urine              N
  32       AB        (indigenous)   NP9                                   RGA               Sputum             N

No = isolate number;

PRA-hsp65

= molecular identification by PCR-Restriction Enzyme Analysis with the

hsp65

gene as target; NP = novel PRA-

hsp65

pattern; TI = traditional identification by phenotypic analysis and biochemical tests; HIV = patient HIV status: P = positive, N = negative, NA = not available; MAC =

M. avium

complex. Isolates with concordant identification by both methods are in bold. Indigenous patients did not have origin information.

PRA-*hsp65* pattern shared by seven species, among them two SGA: *M. avium* 3 and *M. intracellulare* 3, RGA = nonchromogenic rapid grower, RGE = scotochromogenic rapid grower, SGA = nonchromogenic slow grower, SGE = scotochromogenic slow grower.

PRA-*hsp65* assigned 19 (59.4%) NTM cultures a mycobacterial species. Interestingly, culture 14 has been identified as *Nocardia* sp. by traditional identification and the obtained PRA-*hsp65* pattern was recently assigned to *Nocardia brasiliensis* ([@b5]). This confirms that *PRA-hsp65* could be also useful for identification of species of *Nocardia*. PRA restriction patterns from isolate 20 were suggestive of mixed culture but the original culture could not be recovered for further studies. The remaining eleven cultures were distributed in nine novel *PRA-hsp65* patterns, not present in PRA databases (Table 1, [Fig. 1](#fig1){ref-type="fig"}).

![PRA-hsp65 patterns of 32 isolates analyzed using GelCompar II version 2.5.](bjm-39-268-g001){#fig1}

In 15 (46.8%) cultures, traditional identification and PRA-*hsp65* achieved concordant results for a mycobacterial species and this identification was regarded as correct.

Isolate 16 was identified as *M. avium* complex (MAC) by traditional identification and *M. peregrinum* 2 by PRA-hsp65. Laboratory contamination during manipulation of this isolate could not be ruled out, especially as other isolates identified as *M. peregrinum* 2 were obtained in this study. Isolate 15, from the same patient, was also identified as MAC and PRA-*hsp65* resulted in a pattern of BstE II \[235 bp-210 bp\] and *Hae* III \[145 bp-130 bp\], which is shared by seven different species (see [Figure 1](#fig1){ref-type="fig"} and the PRAsite). Two of these seven species are nonchromogenic slow-growers, *M. avium* 3 and *M. intracellulare* 3, which would be in concordance with the phenotypic identification of MAC.

Species identification obtained by PRA-*hsp65* from isolates 17 to 20 could not be confirmed by traditional identification. Two of these isolates, 18 and 19, obtained from sputum from two indigenous patients, were identified by PRA-*hsp65* as *M. lentiflavum*, a species recently identified in Brazilian clinical isolates ([@b16]). *M. lentiflavum* is difficult to identify by conventional methods and the prevalence and clinical significance of such species in Brazil has yet to be fully evaluated.

Culture 28 was identified as *M. gordonae* by traditional identification, but the observed PRA-*hsp65* pattern was not present in available databases. More than ten *PRA-hsp65* patterns have been described for *M. gordonae* and it is considered a highly polymorphic species with respect to PRA-*hsp65* patterns ([@b12]).

Identification by both methods was inconclusive for the remaining ten isolates.

In a similar study performed with isolates from São Paulo State, concordant results of traditional identification and PRA-*hsp65* were obtained in 76 (73.8 %) out of 103 isolates, discordant and inconclusive PRA and/or biochemical results were obtained from 27 (26.2%) isolates ([@b7]). These presence of ten (31.2%) isolates without identification by both methods in the present work suggests the existence of not yet described mycobacterial species in the geographic region studied here, and could explain the lower percentage of conclusive results obtained here.

Medical data from all patients with NTM cultures, with exception of patient Z, were analyzed. Nine patients (A-G, O, and T) had cultures identified as *M. avium* by *PRA-hsp65* and/ or MAC by traditional identification. Four cultures were isolated from sterile sites from three HIV-positive patients and, according to criteria described above, the diagnosis of NTM disease could have been confirmed right away in these cases ([@b10]). *M. avium* was also isolated from feaces (one sample) from a fourth HIV- positive patient. These four patients (A, C, G, and O) received regular treatment for tuberculosis and died during the study. No information about treatment or outcome was available in the clinical files from other patients infected with *M. avium*.

Isolates identified as *M. fortuitum, M. peregrinum, M. kansasii, M. lentiflavum*, and *M.flavescens* were isolated once from sputum. Since these species are potentially pathogenic, the analysis of additional specimens would be required for confirmation of NTM disease ([@b4]). According to medical data, no specific antimicrobial treatment was given to these patients.

Isolate 20 was identified as *M. vaccae* 1 by PRA-hsp65 and was isolated from a sterile site (bone marrow). This species is rarely described as a cause of human disease, but cutaneous and pulmonary infections have been reported in USA ([@b11]). This patient improved after specific treatment for leishmaniasis and the role of *M. vaccae* in the clinical picture could not be confirmed.

Cultures 22 and 23, with identical identification results, were obtained from the same patient with one-week interval. The species could not be determined. This HIV-positive patient had symptoms of pulmonary disease (productive cough, thoracic pain and fever), therefore diagnosis of NTM pulmonary disease could have been confirmed here, but the medical file lacks reference about treatment of this patient.

Isolates 24 and 25 were obtained from the same patient, who had pulmonary symptoms and was treated for tuberculosis and eventually for multi-drug resistant tuberculosis (MDR-TB) for 12 months with no improvement. Both isolates showed the same PRA-hsp65 pattern but the species could not be identified. In this case also, diagnostic criteria for confirmation of NTM pulmonary disease were fulfilled ([@b10]).

Cultures 26 and 27 were obtained from the same patient with one-year interval. This patient was treated for tuberculosis since the first isolate and the disease reactivated after one year. The isolates comprised different mycobacteria, which could not be identified to the species level. The occurrence of two different infections could not be ruled out nor fully confirmed in this case.

This was a retrospective study, but it revealed that eight (20%) from 40 cultures presumptively identified as NTM by macroscopic and microscopic culture characteristics contained *M. tuberculosis*. In addition, at least six (21.4%) out of 28 patients with NTM positive cultures received unnecessary treatment for tuberculosis and even for MDR-TB, probably justified by the presence of AFB smear positive results. Full identification of cultured specimens could have confirmed or excluded tuberculosis and helped to re-direct the therapeutic approach in due time, provided that the proposed diagnostic criteria were observed to confirm disease and exclude specimen contamination ([@b4],[@b10]).

Better management of patients with suspected NTM infections is mandatory and could be obtained by local implementation of rapid methods for identification of mycobacteria. PRA-hsp65 is useful and reliable for separation of *M. tuberculosis* from NTM. Compared to traditional identification, it is quicker (one week versus one to two months), poses less contamination risks, and can be performed in laboratories other than reference centers. Also, reagents' costs are lower in comparison to traditional identification. Other techniques, not performed in the present study, would be useful and should be performed in clinically relevant cases to resolve discordant or inconclusive identification results, specially DNA sequencing of conserved regions, as 16S rDNA, *rpoB*, and *hsp65* genes ([@b1],[@b8]).

RESUMO
======

Identificação de micobactérias não-tuberculosas do Laboratório Central de Saúde Pública de Mato Grosso de Sul e análise de dados clínicos dos pacientes
-------------------------------------------------------------------------------------------------------------------------------------------------------

Micobactérias não-tuberculosas isoladas no Laboratório Central de Saúde Pública de Mato Grosso do Sul em 2003 e 2004 foram identificadas usando métodos fenotípicos convencionais (TI) e PCR-*Restriction Enzyme Analysis* (PRA) tendo o gene *hsp65* como alvo (PRA-hsp65). Em 15 dos 32 isolados analisados os resultados obtidos com ambos métodos foram concordantes, sendo 8 *Mycobacterium avium*, 3 *M. fortutium*, 1 *M. kansasii*, 1 *M. flavescens*, 1 *M. peregrinum* e 1 *Nocardia brasiliensis*. TI de 12 isolados não foi conclusiva. Perfis não descritos de PRA- *hsp65* foram observados com 11 isolados. Dados dos prontuários médicos foram avaliados para inferir a relevência clínica dos isolados.

**Palavras-chave:** Micobactérias, PCR, Identificação.
